• X-Pure®–by-design : Antleron-Rousselot® collaborative-development partnership

    Tuesday October 12th 2021

  • Second edition Medical Solutions Accelerator starts successfully

    Friday October 8th 2021

  • KU Leuven develops very potent antiviral against dengue

    Thursday October 7th 2021

  • Precirix dosed first patients in Phase I/II clinical study evaluating CAM-H2 in HER2-positive metastatic cancer

    Wednesday October 6th 2021

  • atbtherapeutics expands leadership team and Scientific Advisory Board with pharmaceutical industry experts

    Wednesday October 6th 2021

  • New Flanders360 platform puts Flanders’ life sciences & health ecosystem on the international map

    Tuesday October 5th 2021

  • Galapagos announces completion of patient enrollment for DIVERSITY Phase 3 study with filgotinib in Crohn’s Disease

    Monday October 4th 2021

  • Sequana Medical announces FDA approval to expand patient enrolment in North American pivotal alfapump® study (POSEIDON)

    Monday October 4th 2021

  • Your news here?

  • S-Biomedic announces completion of prestigious financing with European Innovation Council Fund

    Friday October 1st 2021

  • Biotalys strengthens executive team with the appointment of Patrick McDonnell as Chief Business Officer

    Thursday September 30th 2021

  • OXURION announces positive results from Part A of Phase 2 Study evaluating THR-149 for treatment of Diabetic Macular Edema (DME)

    Thursday September 30th 2021


Strategic Partners